4 Effects of Endothelin Receptor Antagonist for Pulmonary Arterial Hypertension(The Role of the Endothelin System in Cardiovascular Diseases, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2007-03-01
著者
-
Ono Fumiaki
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
Ono Fumiaki
Internal Medicine National Cardiovascular Center
-
KYOTANI Shingo
Division of Cardiology, National Cardiovascular Center
-
NAKANISHI Norifumi
Division of Cardiology, National Cardiovascular Center
-
Nakanishi Norifumi
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
Kyotani Shingo
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
Kyotani Shingo
Department Of Cardiology National Cardiovascular Medicine
-
Nakanishi Norifumi
Department Of Cardiology National Cardiovascular Medicine
-
Nakanishi Norifumi
Division Of Cardiology And Ccu National Cerebral And Cardiovascular Center
-
Kyotani Shingo
Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center
関連論文
- Usefulness of three-dimensional echocardiography in assessing right ventricular function in patients with primary pulmonary hypertension
- Different Time Course of Changes in Tricuspid Regurgitant Pressure Gradient and Pulmonary Artery Flow Acceleration After Pulmonary Thromboendarterectomy : Implications for Discordant Recovery of Pulmonary Artery Pressure and Compliance
- Discordant Recovery of Pulmonary Artery Pressure and Compliance after Pulmonary Thromboendarterectomy in Patients with Chronin Thromboembolic Pulmonary Hypertension(Pulmonary Circulation 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulatio
- The Efficacy of Long-term Use of Bosentan for Idiopathic Pulmonary Arterial Hypertension (Pulmonary Circulation 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-432 Right Ventricular Function in Patients With Chronic Thromboembolic Pulmonary Hypertension, Before and After Thromboendarterectomy(Pulmonary Circulation 1 (H) : OJ53)(Oral Presentation (Japanese))
- Current Challenge in Thromboendarterectomy for Chronic Pulmonary Thromboembolism with Pulmonary Hypertension ; Prompt Use of PCPS and MUF(Pulmonary Circulation 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Pulmonary Vasodilator Response to Adrenomedullin in Patients with Pulmonary Hypertension
- Beraprost sodium, an orally active prostacyclin analogue, has chronic hemodynamic effects in patients with secondary precapillary pulmonary hypertension
- PJ-828 Plasma Brain Natriuertic Peptide Predicts Prognosis in Patients with Pulmonary Arterial Hypertension Receiving Epoprostenol(Pulmonary circulation-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-284 Efficacy of Radiofrequency Catheter Ablation for Supraventricular Tachycardia in Patients with Pulmonary Hypertension(Arrhythmia, diagnosis/pathophysiology/EPS-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 4 Effects of Endothelin Receptor Antagonist for Pulmonary Arterial Hypertension(The Role of the Endothelin System in Cardiovascular Diseases, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Hemodynamic and Hormonal Effects of Beraprost Sodium, an Orally Active Prostacyclin Analogue, in Patients With Secondary Precapillary Pulmonary Hypertension
- Thyroid Microsomal Antibody Test Predicts Hyperthyroidism during Prostacyclin Therapy in Patients with Primary Pulmonary Hypertention
- Serum Uric Acid Level Increases in Proportion to the Severity of Pulmonary Thromboembolism
- Increased plasma vascular cell adhesion molecule-1 in pulmonary arterial hypertension were improved after long-term prostacyclin therapy
- Long Term Effects of Continuous Intravenous Prostacyclin on Hemodynamics and Cardiac Functions of Pulmonary Hypertension due to Collagen Disease
- Prognoses of Primary Pulmonary Hypertension and Chronic Majorvessel Thromboembolic Pulmonary Hypertension Determined from Cumulative Survival Curves
- Long-term Continuous Intravenous Infusion of Prostacyclin for Severe Primary Pulmonary Hypertension
- FRS-073 Noninvasive Estimation of Pulmonary Vascular Resistance by Doppler Echocardiography in Patients with Pulmonary Hypertension(Leading Edge in Echocardiographic Technologies(1)(I),Featured Research Session,The 72nd Annual Scientific Meeting of the Ja
- PJ-825 Noninvasive Evaluation of Right Ventricular Dysfunction and Disease Severity in Patients with Chronic Pulmonary Arterial Hypertension Using Strain Rate Imaging(Pulmonary circulation-3, The 71st Annual Scientific Meeting of the Japanese Circulation
- Effects of Long-Acting Beraprost Sodium (TRK-100STP) in Japanese Patients With Pulmonary Arterial Hypertension
- A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension
- PJ-537 A Combination of Oral Sildenafil and Beraprost Ameliorates Pulmonary Hypertension in Rats(Pulmonary Circulation 2 (H) : PJ90)(Poster Session (Japanese))
- 1 Pulmonary arterial hypertension due to BMPR2 and ALK1 mutation(Current Therapeutic Strategy for Pulmonary Hypertension,Roundtable Discussion 6 (RT-06) (H),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Management of Continuous Intravenous Prostacyclin Therapy for Pulmonary Arterial Hypertention(The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Management of Continuous Intravenous Prostacyclin Therapy for Pulmonary Hypertension
- Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans
- A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension
- Histopathological Multiple Recanalized Lesion Is Critical Element of Outcome After Pulmonary Thromboendarterectomy
- Role of echocardiography in acute pulmonary embolism.